{
"@context": "https://schema.org",
"@graph": [
{
"@type": "MedicalWebPage",
"name": "Fièvre jaune : Questions médicales les plus fréquentes",
"headline": "Fièvre jaune : Comprendre les symptômes, diagnostics et traitements",
"description": "Guide complet et accessible sur les Fièvre jaune : explications, diagnostics, traitements et prévention. Information médicale validée destinée aux patients.",
"datePublished": "2024-01-06",
"dateModified": "2025-03-31",
"inLanguage": "fr",
"medicalAudience": [
{
"@type": "MedicalAudience",
"name": "Grand public",
"audienceType": "Patient",
"healthCondition": {
"@type": "MedicalCondition",
"name": "Fièvre jaune"
},
"suggestedMinAge": 18,
"suggestedGender": "unisex"
},
{
"@type": "MedicalAudience",
"name": "Médecins",
"audienceType": "Physician",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "France"
}
},
{
"@type": "MedicalAudience",
"name": "Chercheurs",
"audienceType": "Researcher",
"geographicArea": {
"@type": "AdministrativeArea",
"name": "International"
}
}
],
"reviewedBy": {
"@type": "Person",
"name": "Dr Olivier Menir",
"jobTitle": "Expert en Médecine",
"description": "Expert en Médecine, Optimisation des Parcours de Soins et Révision Médicale",
"url": "/static/pages/docteur-olivier-menir.html",
"alumniOf": {
"@type": "EducationalOrganization",
"name": "Université Paris Descartes"
}
},
"isPartOf": {
"@type": "MedicalWebPage",
"name": "Fièvres hémorragiques virales",
"url": "https://questionsmedicales.fr/mesh/D006482",
"about": {
"@type": "MedicalCondition",
"name": "Fièvres hémorragiques virales",
"code": {
"@type": "MedicalCode",
"code": "D006482",
"codingSystem": "MeSH"
},
"identifier": {
"@type": "PropertyValue",
"propertyID": "MeSH Tree",
"value": "C01.925.782.417"
}
}
},
"about": {
"@type": "MedicalCondition",
"name": "Fièvre jaune",
"alternateName": "Yellow Fever",
"code": {
"@type": "MedicalCode",
"code": "D015004",
"codingSystem": "MeSH"
}
},
"author": [
{
"@type": "Person",
"name": "Pedro Augusto Alves",
"url": "https://questionsmedicales.fr/author/Pedro%20Augusto%20Alves",
"affiliation": {
"@type": "Organization",
"name": "Instituto René Rachou/Fundação Oswaldo Cruz, 30190-002 Belo Horizonte, Minas Gerais, Brazil."
}
},
{
"@type": "Person",
"name": "Erna Geessien Kroon",
"url": "https://questionsmedicales.fr/author/Erna%20Geessien%20Kroon",
"affiliation": {
"@type": "Organization",
"name": "Departament of Microbiology, Universidade Federal de Minas Gerais, 31270-901 Belo Horizonte, Minas Gerais, Brazil."
}
},
{
"@type": "Person",
"name": "Betânia Paiva Drumond",
"url": "https://questionsmedicales.fr/author/Bet%C3%A2nia%20Paiva%20Drumond",
"affiliation": {
"@type": "Organization",
"name": "Departament of Microbiology, Universidade Federal de Minas Gerais, 31270-901 Belo Horizonte, Minas Gerais, Brazil."
}
},
{
"@type": "Person",
"name": "Anna-Bella Failloux",
"url": "https://questionsmedicales.fr/author/Anna-Bella%20Failloux",
"affiliation": {
"@type": "Organization",
"name": "Institut Pasteur, Université Paris Cité, Arboviruses and Insect Vectors, Paris, France. anna-bella.failloux@pasteur.fr."
}
},
{
"@type": "Person",
"name": "Laurence Cibrelus",
"url": "https://questionsmedicales.fr/author/Laurence%20Cibrelus",
"affiliation": {
"@type": "Organization",
"name": "World Health Organisation, Geneva, Switzerland."
}
}
],
"citation": [
{
"@type": "ScholarlyArticle",
"name": "EGFR inhibition reverses resistance to lenvatinib in hepatocellular carcinoma cells.",
"datePublished": "2022-05-14",
"url": "https://questionsmedicales.fr/article/35568782",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41598-022-12076-w"
}
},
{
"@type": "ScholarlyArticle",
"name": "Drug resistant epilepsy of the insular lobe: A review and update article.",
"datePublished": "2022-05-13",
"url": "https://questionsmedicales.fr/article/35673654",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.25259/SNI_58_2022"
}
},
{
"@type": "ScholarlyArticle",
"name": "Systems approaches to uncovering the contribution of environment-mediated drug resistance.",
"datePublished": "2022-05-13",
"url": "https://questionsmedicales.fr/article/36321161",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1016/j.cossms.2022.101005"
}
},
{
"@type": "ScholarlyArticle",
"name": "Evaluating the Potential and Synergetic Effects of Microcins against Multidrug-Resistant",
"datePublished": "2022-05-11",
"url": "https://questionsmedicales.fr/article/35543514",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1128/spectrum.02752-21"
}
},
{
"@type": "ScholarlyArticle",
"name": "Third-generation EGFR and ALK inhibitors: mechanisms of resistance and management.",
"datePublished": "2022-05-09",
"url": "https://questionsmedicales.fr/article/35534623",
"identifier": {
"@type": "PropertyValue",
"propertyID": "DOI",
"value": "10.1038/s41571-022-00639-9"
}
}
],
"breadcrumb": {
"@type": "BreadcrumbList",
"itemListElement": [
{
"@type": "ListItem",
"position": 1,
"name": "questionsmedicales.fr",
"item": "https://questionsmedicales.fr"
},
{
"@type": "ListItem",
"position": 2,
"name": "Infection",
"item": "https://questionsmedicales.fr/mesh/D007239"
},
{
"@type": "ListItem",
"position": 3,
"name": "Maladies virales",
"item": "https://questionsmedicales.fr/mesh/D014777"
},
{
"@type": "ListItem",
"position": 4,
"name": "Infections à virus à ARN",
"item": "https://questionsmedicales.fr/mesh/D012327"
},
{
"@type": "ListItem",
"position": 5,
"name": "Fièvres hémorragiques virales",
"item": "https://questionsmedicales.fr/mesh/D006482"
},
{
"@type": "ListItem",
"position": 6,
"name": "Fièvre jaune",
"item": "https://questionsmedicales.fr/mesh/D015004"
}
]
}
},
{
"@type": "MedicalWebPage",
"name": "Article complet : Fièvre jaune - Questions et réponses",
"headline": "Questions et réponses médicales fréquentes sur Fièvre jaune",
"description": "Une compilation de questions et réponses structurées, validées par des experts médicaux.",
"datePublished": "2025-05-06",
"inLanguage": "fr",
"hasPart": [
{
"@type": "MedicalWebPage",
"name": "Diagnostic",
"headline": "Diagnostic sur Fièvre jaune",
"description": "Comment diagnostique-t-on la fièvre jaune ?\nQuels tests sont utilisés pour confirmer la fièvre jaune ?\nQuels symptômes indiquent une fièvre jaune ?\nLa fièvre jaune peut-elle être confondue avec d'autres maladies ?\nQuel rôle joue l'historique de voyage dans le diagnostic ?",
"url": "https://questionsmedicales.fr/mesh/D015004?mesh_terms=Methicillin-Resistant+Staphylococcus+aureus&page=1000#section-diagnostic"
},
{
"@type": "MedicalWebPage",
"name": "Symptômes",
"headline": "Symptômes sur Fièvre jaune",
"description": "Quels sont les premiers symptômes de la fièvre jaune ?\nLa jaunisse est-elle un symptôme de la fièvre jaune ?\nQuels symptômes indiquent une forme sévère de la maladie ?\nLes symptômes de la fièvre jaune évoluent-ils rapidement ?\nPeut-on avoir des symptômes sans être infecté ?",
"url": "https://questionsmedicales.fr/mesh/D015004?mesh_terms=Methicillin-Resistant+Staphylococcus+aureus&page=1000#section-symptômes"
},
{
"@type": "MedicalWebPage",
"name": "Prévention",
"headline": "Prévention sur Fièvre jaune",
"description": "Comment se protéger contre la fièvre jaune ?\nLa vaccination est-elle efficace contre la fièvre jaune ?\nÀ quel âge peut-on se faire vacciner contre la fièvre jaune ?\nFaut-il un certificat de vaccination pour voyager ?\nLes moustiquaires sont-elles utiles pour la prévention ?",
"url": "https://questionsmedicales.fr/mesh/D015004?mesh_terms=Methicillin-Resistant+Staphylococcus+aureus&page=1000#section-prévention"
},
{
"@type": "MedicalWebPage",
"name": "Traitements",
"headline": "Traitements sur Fièvre jaune",
"description": "Quel est le traitement principal pour la fièvre jaune ?\nLes antibiotiques sont-ils efficaces contre la fièvre jaune ?\nComment gérer la déshydratation due à la fièvre jaune ?\nDes soins intensifs sont-ils nécessaires pour les cas graves ?\nPeut-on prévenir la fièvre jaune par des traitements ?",
"url": "https://questionsmedicales.fr/mesh/D015004?mesh_terms=Methicillin-Resistant+Staphylococcus+aureus&page=1000#section-traitements"
},
{
"@type": "MedicalWebPage",
"name": "Complications",
"headline": "Complications sur Fièvre jaune",
"description": "Quelles sont les complications possibles de la fièvre jaune ?\nLa fièvre jaune peut-elle entraîner la mort ?\nQuels organes peuvent être affectés par la fièvre jaune ?\nLes complications surviennent-elles rapidement ?\nPeut-on récupérer complètement après des complications ?",
"url": "https://questionsmedicales.fr/mesh/D015004?mesh_terms=Methicillin-Resistant+Staphylococcus+aureus&page=1000#section-complications"
},
{
"@type": "MedicalWebPage",
"name": "Facteurs de risque",
"headline": "Facteurs de risque sur Fièvre jaune",
"description": "Qui est le plus à risque de contracter la fièvre jaune ?\nLes voyageurs doivent-ils se faire vacciner avant de partir ?\nLes personnes âgées sont-elles plus vulnérables ?\nLes personnes immunodéprimées sont-elles à risque ?\nLes conditions de vie influencent-elles le risque ?",
"url": "https://questionsmedicales.fr/mesh/D015004?mesh_terms=Methicillin-Resistant+Staphylococcus+aureus&page=1000#section-facteurs de risque"
}
]
},
{
"@type": "FAQPage",
"mainEntity": [
{
"@type": "Question",
"name": "Comment diagnostique-t-on la fièvre jaune ?",
"position": 1,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le diagnostic repose sur les symptômes cliniques et des tests sanguins pour détecter le virus."
}
},
{
"@type": "Question",
"name": "Quels tests sont utilisés pour confirmer la fièvre jaune ?",
"position": 2,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les tests sérologiques et la PCR sont utilisés pour confirmer la présence du virus."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une fièvre jaune ?",
"position": 3,
"acceptedAnswer": {
"@type": "Answer",
"text": "Fièvre, frissons, douleurs musculaires, et jaunisse sont des symptômes clés."
}
},
{
"@type": "Question",
"name": "La fièvre jaune peut-elle être confondue avec d'autres maladies ?",
"position": 4,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, elle peut être confondue avec la dengue ou l'hépatite virale."
}
},
{
"@type": "Question",
"name": "Quel rôle joue l'historique de voyage dans le diagnostic ?",
"position": 5,
"acceptedAnswer": {
"@type": "Answer",
"text": "Un historique de voyage dans des zones endémiques est crucial pour le diagnostic."
}
},
{
"@type": "Question",
"name": "Quels sont les premiers symptômes de la fièvre jaune ?",
"position": 6,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les premiers symptômes incluent fièvre, frissons, et douleurs musculaires."
}
},
{
"@type": "Question",
"name": "La jaunisse est-elle un symptôme de la fièvre jaune ?",
"position": 7,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la jaunisse apparaît souvent dans les cas avancés de fièvre jaune."
}
},
{
"@type": "Question",
"name": "Quels symptômes indiquent une forme sévère de la maladie ?",
"position": 8,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des saignements, des douleurs abdominales et une défaillance organique signalent une forme sévère."
}
},
{
"@type": "Question",
"name": "Les symptômes de la fièvre jaune évoluent-ils rapidement ?",
"position": 9,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les symptômes peuvent évoluer rapidement, nécessitant une attention médicale urgente."
}
},
{
"@type": "Question",
"name": "Peut-on avoir des symptômes sans être infecté ?",
"position": 10,
"acceptedAnswer": {
"@type": "Answer",
"text": "Des symptômes similaires peuvent apparaître sans infection, nécessitant un diagnostic précis."
}
},
{
"@type": "Question",
"name": "Comment se protéger contre la fièvre jaune ?",
"position": 11,
"acceptedAnswer": {
"@type": "Answer",
"text": "Utilisez des répulsifs, portez des vêtements longs et évitez les zones à moustiques."
}
},
{
"@type": "Question",
"name": "La vaccination est-elle efficace contre la fièvre jaune ?",
"position": 12,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la vaccination est très efficace et recommandée pour les voyageurs dans les zones à risque."
}
},
{
"@type": "Question",
"name": "À quel âge peut-on se faire vacciner contre la fièvre jaune ?",
"position": 13,
"acceptedAnswer": {
"@type": "Answer",
"text": "La vaccination est recommandée à partir de 9 mois."
}
},
{
"@type": "Question",
"name": "Faut-il un certificat de vaccination pour voyager ?",
"position": 14,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, un certificat de vaccination peut être exigé pour entrer dans certains pays."
}
},
{
"@type": "Question",
"name": "Les moustiquaires sont-elles utiles pour la prévention ?",
"position": 15,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les moustiquaires traitées sont efficaces pour réduire les piqûres de moustiques."
}
},
{
"@type": "Question",
"name": "Quel est le traitement principal pour la fièvre jaune ?",
"position": 16,
"acceptedAnswer": {
"@type": "Answer",
"text": "Il n'existe pas de traitement antiviral spécifique; le traitement est symptomatique."
}
},
{
"@type": "Question",
"name": "Les antibiotiques sont-ils efficaces contre la fièvre jaune ?",
"position": 17,
"acceptedAnswer": {
"@type": "Answer",
"text": "Non, les antibiotiques ne sont pas efficaces car la fièvre jaune est causée par un virus."
}
},
{
"@type": "Question",
"name": "Comment gérer la déshydratation due à la fièvre jaune ?",
"position": 18,
"acceptedAnswer": {
"@type": "Answer",
"text": "L'hydratation par voie intraveineuse est essentielle pour gérer la déshydratation."
}
},
{
"@type": "Question",
"name": "Des soins intensifs sont-ils nécessaires pour les cas graves ?",
"position": 19,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les cas graves peuvent nécessiter des soins intensifs pour surveiller les organes."
}
},
{
"@type": "Question",
"name": "Peut-on prévenir la fièvre jaune par des traitements ?",
"position": 20,
"acceptedAnswer": {
"@type": "Answer",
"text": "La prévention repose principalement sur la vaccination, pas sur des traitements."
}
},
{
"@type": "Question",
"name": "Quelles sont les complications possibles de la fièvre jaune ?",
"position": 21,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications incluent l'insuffisance hépatique, les saignements et le choc."
}
},
{
"@type": "Question",
"name": "La fièvre jaune peut-elle entraîner la mort ?",
"position": 22,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la fièvre jaune peut être mortelle, surtout sans traitement approprié."
}
},
{
"@type": "Question",
"name": "Quels organes peuvent être affectés par la fièvre jaune ?",
"position": 23,
"acceptedAnswer": {
"@type": "Answer",
"text": "Le foie, les reins et le cœur peuvent être gravement affectés par la maladie."
}
},
{
"@type": "Question",
"name": "Les complications surviennent-elles rapidement ?",
"position": 24,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les complications peuvent survenir dans les 7 à 10 jours suivant l'infection."
}
},
{
"@type": "Question",
"name": "Peut-on récupérer complètement après des complications ?",
"position": 25,
"acceptedAnswer": {
"@type": "Answer",
"text": "Certaines personnes peuvent récupérer complètement, mais d'autres peuvent avoir des séquelles."
}
},
{
"@type": "Question",
"name": "Qui est le plus à risque de contracter la fièvre jaune ?",
"position": 26,
"acceptedAnswer": {
"@type": "Answer",
"text": "Les personnes vivant ou voyageant dans des zones endémiques sont les plus à risque."
}
},
{
"@type": "Question",
"name": "Les voyageurs doivent-ils se faire vacciner avant de partir ?",
"position": 27,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, la vaccination est fortement recommandée pour les voyageurs vers des zones à risque."
}
},
{
"@type": "Question",
"name": "Les personnes âgées sont-elles plus vulnérables ?",
"position": 28,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes âgées peuvent avoir un risque accru de complications graves."
}
},
{
"@type": "Question",
"name": "Les personnes immunodéprimées sont-elles à risque ?",
"position": 29,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, les personnes immunodéprimées courent un risque plus élevé de maladie sévère."
}
},
{
"@type": "Question",
"name": "Les conditions de vie influencent-elles le risque ?",
"position": 30,
"acceptedAnswer": {
"@type": "Answer",
"text": "Oui, vivre dans des zones avec des moustiques augmente le risque de transmission."
}
}
]
}
]
}
Hepatocellular carcinoma (HCC) is a leading cause of cancer-related death worldwide. Lenvatinib is approved as a first-line treatment for unresectable HCC. The therapeutic duration of lenvatinib is li...
Epilepsy is a chronic disease that affects millions of people around the world generating great expenses and psychosocial problems burdening the public health in different ways. A considerable number ...
A literature review was performed using MEDLINE/PubMed, Scopus, and Web of Science databases. The terms epilepsy/epileptic seizure of the insula and surgical treatment was used in various combinations...
Initial search results in 1267 articles. After removing the duplicates 710 remaining articles were analyzed for titles and abstracts applying the inclusion and exclusion criteria. 70 studies met all i...
At present, the main interests and efforts are in the attempt to achieve and standardize the adequate management of the patient with refractory epilepsy of the insular lobe and for that purpose severa...
Cancer drug response is heavily influenced by the extracellular matrix (ECM) environment. Despite a clear appreciation that the ECM influences cancer drug response and progression, a unified view of h...
The advent of multidrug-resistant bacteria has hampered the development of new antibiotics, exacerbating their morbidity and mortality. In this context, the gastrointestinal tract reveals a valuable s...
The discoveries of EGFR mutations and ALK rearrangements as actionable oncogenic drivers in non-small-cell lung cancer (NSCLC) has propelled a biomarker-directed treatment paradigm for patients with a...
The purpose of this paper is to provide a conceptual overview of resistance and argue for the need to embrace resistance as a part of nurses' professional repertoire for disrupting inequities and fost...
Discursive article....
Published peer reviewed literature on 'resistance' and 'professional resistance' in nursing, medicine, social work and other allied health care professions....
Enhancing critical consciousness and engaging in intersectional collaboration are promising strategies to embrace resistance for collective action towards disrupting inequities and injustices in nursi...
Embracing and legitimising resistance in everyday individual and social interactions in educational and practice settings is instrumental to fostering social justice in nursing. Without resistance, nu...
Nurses can embrace resistance in practice to counteract social injustice and promote diversity, equity, inclusion and belonging and antiracism in clinical and educational settings....
Research demonstrated that perceived and real inequities and injustices are common in nursing in the form of individual and structural racism, sex and gender discrimination, power imbalances and inciv...
There was no patient or public involvement in the design or writing of this discursive article....
Absolute prevalence of tobacco smoking has fallen in recent decades but inequalities by socioeconomic position (SEP) persist. Adolescence is a critical period for smoking initiation and habits formed ...
Assembly of metagenomic samples can provide essential information about the mobility potential and taxonomic origin of antibiotic resistance genes (ARGs) and inform interventions to prevent further sp...
The results revealed that none of the investigated tools can accurately capture genomic contexts present in samples of high complexity. The transcriptomic assembler Trinity showed a better performance...
Our study shows that metaSPAdes and Trinity would be the preferable tools in terms of accuracy to recover correct genomic contexts around ARGs in metagenomic samples characterized by uneven coverages....
Inflammation has a pivotal role in the initiation and progression of various cancers, contributing to crucial processes such as metastasis, angiogenesis, cell proliferation and invasion. Moreover, the...
Antimicrobial resistance is a global health threat resulting in significant morbidity and mortality worldwide. Until recently, in Ukraine, cumulative antibiograms (CuAbgms) have never been available....
To describe the first CuAbgm developed in Ukraine....
We developed a CuAbgm for the Okhmatdyt National Specialized Children's Hospital using data from WHONET. Antimicrobial susceptibility testing was performed per EUCAST guidelines. The CuAbgm was develo...
For...
In this first-ever CuAbgm developed in Ukraine, high levels of resistance were demonstrated among Gram-negative bacteria. CuAbgms should be prioritized in laboratories in Ukraine to guide empirical an...